TR-1: Notification of Major Interest in Shares

RNS Number : 3501Y

Alliance Pharma PLC

23 January 2014

 



For immediate release

23 January 2014

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

TR-1: Notification of Major Interest in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Alliance Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	On market transfer between direct and indirect funds			x
3. Full name of person(s) subject to the notification obligation:		Aviva plc & its subsidiaries
4. Full name of shareholder(s)  (if different from 3.):		Registered Holder: BNY (Nominees)Limited                                 212,570*             BNY Norwich Union Nominees Limited    2,785,299* Chase (GA Group) Nominees Limited       19,974,014* Vidacos Nominees Limited                              157,711* *denotes direct interest Chase Nominees Limited                                 956,282
5. Date of the transaction and date on which the threshold is crossed or reached:		21 January 2014
6. Date on which issuer notified:		22 January 2014
7. Threshold(s) that is/are crossed or reached:		9% to 8% Change at Direct Interest Level

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction				Resulting situation after the triggering transaction
	Number of Shares		Number of Voting Rights		Number of shares	Number of voting rights			% of  voting rights
					Direct	Direct		Indirect	Direct		Indirect
Ordinary Shares GB0031030819	24,316,755		24,316,755		24,085,876	23,129,594		956,282	8.76%		0.36%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Expiration date		Exercise/ Conversion Period			Number of voting rights that may be acquired if the instrument is exercised/ converted.			% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date	Exercise/ Conversion period	Number of voting rights instrument refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)
Number of voting rights	Percentage of voting rights
24,085,876	9.12%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: ·      Aviva plc (Parent Company) ·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) ·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
10. Name of the proxy holder:		See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Figures are based on a total number of voting rights of  264,080,873 as per the Company's CULS Conversion and Additional Listing Announcement of 19 December 2013.
14. Contact name:	Neil Whittaker, Aviva plc
15. Contact telephone number:	01603 684420

 

END

 

 

HOLKXLBLZFFFBBL